Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Electro-conductive and immunomodulatory macroporous hydrogel conduit for faster spinal cord regeneration | Dr. Akshay Srivastava, Associate Professor, National Institute of Pharmaceutical Education and Research, Ahmedabad | 2022 | Medical Devices | |
| Antipyretic, antimalarial evaluation and formulation development studies of dried fish extracts and fermented fish preparations belonging to the Punitus species | Dr. Chandrajit Dohutia, Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti | 2022 | Antimalarial Evaluation | |
| Therapeutic Significance of MARCKS Signaling Axis in Ovarian Cancer Metastasis: A Precision Anti-Metastatic Therapy Approach | Dr. Purusottam Mohapatra, DBT Ramalingaswami Fellow, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2022 | Biotechnology, Ovarian Cancer Metastasis | |
| Exercise Imitating microRNA Lipodendriplex for the prevention and treatment of obesity | Prof. Rakesh Kumar Tekade, Associate Professor, National Institute of Pharmaceutical Education and Research, Ahmedabad | 2022 | Pharmaceutics, Genetic Engineering | |
| Development of functionalized dual loaded herbal nano-colloidal carrier: Active targeting and repositioning of teriflunomide for synergistically enhancing role of sulphoraphane in combating triple negative breast cancer | Dr. Sushama Talegaonkar, Associate Professor, Delhi Pharmaceutical Sciences and Research University | 2021 | Pharmacology, Toxicology | |
| Deciphering the redox chemistry of physical plasma-treated clinically-relevant liquids as novel therapy against ovarian cancer | Dr. Naresh Kumar, Ramalingaswami fellow, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2021 | Pharmacology, Toxicology | |
| IND enabling studies and development of CDRI-4655 as anti-hyper-triglyceridemic formulation | Dr Anil Nilkanth Gaikwad, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Chemotherapeutic development |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Prof Sanjeeva Srivastava, Assistant Professor, Indian Institute of Technology (IIT) Bombay, Dr Om Shrivastav, Director, , Jaslok Hospital, Mumbai, Dr Jayanthi S. Shastri, Professor & Head, T N Medical College & Nair Hospital, Dr Mala Vinod Kaneria, Jaslok Hospital, Mumbai | 2020 | Drug repurposing for COVID-19 | |
| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Dr Thenmalarchelvi, Associate Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | Drug repurposing for COVID-19 | |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |